{"id":12903,"date":"2017-08-17T23:42:02","date_gmt":"2017-08-17T15:42:02","guid":{"rendered":"http:\/\/biopioneer.com.tw\/?p=12903"},"modified":"2022-07-21T11:22:53","modified_gmt":"2022-07-21T03:22:53","slug":"vp1-%e5%8f%a3%e8%b9%84%e7%96%ab%e7%97%85%e6%af%92%e9%87%8d%e7%b5%84%e5%96%ae%e6%a0%aa%e6%8a%97%e9%ab%94-recombinant-monoclonal-antibody-to-vp1%e8%b2%a8%e8%99%9fab00939-2-0","status":"publish","type":"post","link":"http:\/\/biopioneer.com.tw\/?p=12903","title":{"rendered":"VP1 \u53e3\u8e44\u75ab\u75c5\u6bd2\u91cd\u7d44\u55ae\u682a\u6297\u9ad4 |Recombinant monoclonal antibody to VP1\u8ca8\u865fAb00939-2.0"},"content":{"rendered":"

Anti-VP1 [4C4] \u53e3\u8e44\u75ab\u75c5\u6bd2\u91cd\u7d44\u55ae\u682a\u6297\u9ad4 | \u8ca8\u865fAb00939-2.0<\/a><\/span><\/p>\n

\u7522\u54c1\u4ecb\u7d39<\/strong>:<\/strong> VP1\u53e3\u8e44\u75ab\u75c5\u6bd2\u91cd\u7d44\u55ae\u682a\u6297\u9ad4 \/ \u5c0f\u9f20IgG2a\uff0ckappa (Clone Number: 4C4)\u3002\u4f7f\u7528\u4f86\u81ea\u96dc\u4ea4\u76244C4\u7684\u53ef\u8b8a\u5340\u53ef\u8b8a\u5340\uff08\u5373\u7279\u7570\u6027\uff09\u3002\u514d\u75ab\u539f\u91dd\u5c0dFMDV\u7684C1\u578bBrescia It \/ 64\u83cc\u682a\u7522\u751f\u9f20\u6297\u9ad4\u3002\u7279\u7570\u6027\uff1a4C4\u7279\u7570\u6027\u7d50\u5408C\u578bFMDV\u8863\u6bbc\u86cb\u767dVP1\u7684G-H\u74b0\uff0c\u4e5f\u7a31\u6297\u539f\u4f4d\u9edeA.\u9019\u7a2e\u7279\u7570\u6027\u7531\u6591\u584a\u6e1b\u5c11\u4e2d\u548c\u6e2c\u5b9a\uff08Verdaguer\u7b49\u4eba\uff0c1999\uff09\u4ee5\u53ca\u66f4\u8fd1\u671f\u7684\u6676\u9ad4\u5b78\u6578\u64da\uff08Verdaguer\u7b49\u4eba\uff0c1998; Ochoa\u7b49\u4eba\uff0c2000\uff09\u652f\u6301\u3002 VP1\u662f\u5bbf\u4e3b\u7d30\u80de\u8b58\u5225\u6240\u9700\u7684\u5916\u6bbc\u86cb\u767d\uff0c\u4e26\u4e14\u53ef\u4ee5\u4fc3\u9032\u611f\u67d3\u671f\u9593\u7684FMDV\u9032\u5165\u3002\u53e3\u8e44\u75ab\u6703\u5f71\u97ff\u725b\u7a2e\uff0c\u5728\u67d0\u4e9b\u60c5\u6cc1\u4e0b\u53ef\u80fd\u662f\u81f4\u547d\u7684\u30024C4\u5c0d\u8840\u6e05\u578bC FMDV\u7684VP1 G-H\u74b0\u6216\u6297\u539f\u6027\u4f4d\u9edeA\u5177\u6709\u5f37\u70c8\u7684\u4e2d\u548c\u6d3b\u6027\u3002\u5df2\u7d93\u4f7f\u7528\u566c\u83cc\u6591\u6e1b\u5c11\uff08\u4e2d\u548c\uff09\u6e2c\u5b9a\u4ee5\u53caELISA\u548c\u514d\u75ab\u5370\u8de1\uff08Mateu\u7b49\u4eba\uff0c1992,1989,1990\uff09\u3002<\/p>\n

Published Application(s): <\/strong>NTRL; crystallisation; ELISA; WB Published Species Reactivity: <\/strong>Foot-and-mouth disease virus<\/p>\n

\u6297\u75c5\u6bd2\u6297\u9ad4<\/strong>\u7cfb\u5217\u5546\u54c1<\/strong><\/p>\n

Absoluteantibody\u63d0\u4f9b\u4e00\u7cfb\u5217\u91dd\u5c0d\u75c5\u6bd2\u6297\u539f\u7684\u91cd\u7d44\u6297\u9ad4\u3002\u6297\u9ad4\u6700\u521d\u901a\u904eHybridoma\u6280\u8853\uff0cphage-display\u566c\u83cc\u9ad4\u5c55\u793a\u6280\u8853\u6216\u4f86\u81ea\u611f\u67d3\u7684\u4eba\u985e\u60a3\u8005\u7684\uff08\u6c38\u751f\u5316\uff09B\u7d30\u80de\u7684sequencing\u7522\u751f\u3002\u4f7f\u7528Cellclone\u6280\u8853\u5f9e\u771f\u5be6\u7684\u4eba\u985e\u60a3\u8005\u4e2d\u63d0\u4f9b\u4e86\u4e00\u7cfb\u5217\u7531Humabs BioMed SA\u7522\u751f\u7684\u6297\u9ad4\u3002\u6297\u9ad4\u9069\u7528\u65bcpre-clinical research\u81e8\u5e8a\u524d\u7814\u7a76\uff0c\u4e26\u5c0d\u4e0b\u5217\u7528\u9014\u9032\u884c\u9a57\u8b49\u3002<\/p>\n

\u75c5\u6bd2\u6297\u9ad4<\/span><\/strong> Anti-VP1<\/a>\u00a0| HA Influenza A Virus\u00a0\u55ae\u682a\u6297\u9ad4 <\/a>\u00a0| \u725b\u75d8\u75c5\u6bd2A14\u78f7\u86cb\u767d<\/a>\u00a0| CHIKV E2 B\u7d50\u69cb\u57df<\/u> | CHIKV E2 B\u7d50\u69cb\u57df<\/u> | E\u86cb\u767d\u4e09\u805a\u9ad4\uff08DENV3\uff09 <\/a><\/strong><\/span><\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Product Name<\/a><\/strong><\/td>\nExpected Species Reactivity<\/a><\/strong><\/td>\nApplications<\/a><\/strong><\/td>\n<\/tr>\n<\/thead>\n
Anti-Ebola GP [h-13F6]<\/a><\/td>\nEBOV (Zaire)<\/td>\nIP; SPR; ELISA<\/td>\n<\/tr>\n
Anti-Ebola Nucleoprotein [KZ51]<\/a><\/td>\nEbola Virus (Zaire, Ivory Coast, Reston, Sudan)<\/td>\nELISA; WB; IP; IF<\/td>\n<\/tr>\n
Anti-Ebola surface glycoprotein [KZ52]<\/a><\/td>\nEbola (Zaire)<\/td>\nNTRL; IF; IP; crystallization<\/td>\n<\/tr>\n
Anti-EDIII [2D73]<\/a><\/td>\nDENV<\/td>\nELISA; crystallisation<\/td>\n<\/tr>\n
Anti-Envelope dimer Epitope 1 [752-2C8]<\/a><\/td>\nDengue Virus; Zika Virus<\/td>\nNTRL; ELISA; crystallization<\/td>\n<\/tr>\n
Anti-Envelope dimer Epitope 1 [753(3) C10]<\/a><\/td>\nDengue Virus; Zika Virus<\/td>\nNTRL; ELISA; crystallization<\/td>\n<\/tr>\n
Anti-Envelope dimer Epitope 2 [747(4) A11]<\/a><\/td>\nDengue Virus; Zika Virus<\/td>\nNTRL; ELISA; crystallization<\/td>\n<\/tr>\n
Anti-Envelope dimer Epitope 2 [747(4) B7]<\/a><\/td>\nDengue Virus; Zika Virus<\/td>\nNTRL; ELISA; crystallization<\/td>\n<\/tr>\n
Anti-Envelope glycoprotein Gc [A5]<\/a><\/td>\nHantavirus<\/td>\ncrystallization; SPR<\/td>\n<\/tr>\n
Anti-Envelope protein [ZKA64]<\/a><\/td>\nZika Virus<\/td>\nNTRL; enhance; FC; ELISA<\/td>\n<\/tr>\n
Anti-Envelope protein [ZKA78]<\/a><\/td>\nZika Virus; Dengue Virus<\/td>\nNTRL; enhance; FC; ELISA<\/td>\n<\/tr>\n
Anti-Envelope protein DIII [E111]<\/a><\/td>\nDENV-1<\/td>\nNTRL; FC; WB; IP; IHC; IF<\/td>\n<\/tr>\n
Anti-Filovirus GP [Mr78]<\/a><\/td>\nMarburg Virus; Ebola Virus<\/td>\nNTRL; ELISA<\/td>\n<\/tr>\n
Anti-Flavivirus group antigen [D1-4G2-4-15 (4G2)]<\/a><\/td>\nDengue Virus; Zika Virus; West Nile Virus; Yellow Fever Virus; Flaviviridae<\/td>\nIF; WB; NTRL; ELISA; FC; IHC-P<\/td>\n<\/tr>\n
Anti-gH [YC15]<\/a><\/td>\nKSHV<\/td>\nWB; NTRL; IHC; FC<\/td>\n<\/tr>\n
Anti-gH [YC15]<\/a><\/td>\nKSHV<\/td>\nFC; NTRL<\/td>\n<\/tr>\n
Anti-Glycoprotein D of HSV [E317]<\/a><\/td>\nHerpes Simplex Virus<\/td>\nELISA; IP; Blocking<\/td>\n<\/tr>\n
Anti-Glycoprotein H [A13-d6.3]<\/a><\/td>\npseudorabies virus (PrV)<\/td>\nneutralize; crystalize; immunostaining<\/td>\n<\/tr>\n
Anti-GP1 [GD01]<\/a><\/td>\nJunin virus (JUNV)<\/td>\nneutralize; crystallize; ELISA<\/td>\n<\/tr>\n
Anti-H3N2 antigen from influenza A virus [IF1A11]<\/a><\/td>\nInfluenza A<\/td>\nELISA; WB; Blocking<\/td>\n<\/tr>\n
Anti-HA [FB75]<\/a><\/td>\nInfluenza A Virus (several subtypes)<\/td>\nNTRL; ELISA<\/td>\n<\/tr>\n
Anti-HA [FC41]<\/a><\/td>\nInfluenza A Virus (several subtypes)<\/td>\nELISA<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

Anti-VP1 [4C4] \u53e3\u8e44\u75ab\u75c5\u6bd2\u91cd\u7d44\u55ae\u682a\u6297\u9ad4 | \u8ca8\u865fAb00939-2.0 \u7522\u54c1\u4ecb\u7d39: VP1\u53e3\u8e44\u75ab […]<\/p>\n","protected":false},"author":3,"featured_media":659,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[514],"tags":[3341],"_links":{"self":[{"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/12903"}],"collection":[{"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=12903"}],"version-history":[{"count":3,"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/12903\/revisions"}],"predecessor-version":[{"id":12909,"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/12903\/revisions\/12909"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/media\/659"}],"wp:attachment":[{"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=12903"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=12903"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=12903"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}